124. Cohen S, Alonso MJ, Langer R (1994) Novel approaches to controlled release antigen
delivery. Int J Technol Assess Health Care 10:121–130
125. Jean-Christophe L, Eric A, Fanny DJ et al (1996) Biodegradable nanoparticles-from
sustained release formulations to improved site specific drug delivery. J Control Release
39:339–350
126. Kumari A, Yadav SK, Pakade YB et al (2011) Nanoencapsulation and characterization of
Albizia chinensis isolated antioxidant quercitrin on PLA nanoparticles. Colloids Surf B
Biointerfaces 82:224–232
127. Hu FX, Neoh KG, Kang ET (2006) Synthesis and in vitro anti-cancer evaluation of
tamoxifen-loaded magnetite/PLLA composite nanoparticles. Biomaterials 27:5725–5733
128. Leenstag JW, Pennings AJ, Bos RRM et al (1987) Resorbable materials of polyl-lactides VI.
Plates and screws for internal fracture fixation. Biomaterials 8:70–73
129. Pathiraja AG, Raju A (2003) Biodegradable synthetic polymers for tissue engineering. Eur
Cell Mater 5:1–16
130. Sheridan MH, Shea LD, Peters MC (2000) Bioabsorbable polymer scaffolds for tissue
engineering capable of sustained growth factor delivery. J Control Release 64:91–102
131. Panyam J, Labhasetwar V (2003) Dynamics of endocytosis and exocytosis of poly (L-lactideco-glycolide) nanoparticles in vascular smooth muscle cells. Pharm Res 20:212–220
132. Prabha S, Labhasetwar V (2004) Critical determinants in PLGA/PLA nanoparticle-mediated
gene expression. Pharm Res 21:354–364
133. Athanasiou KA, Niederauer GG, Agrawal CM (1996) Sterilization, toxicity, biocompatibility
and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials
17:93–102
134. Mittal G, Sahana DK, Bhardwaj V et al (2007) Estradiol loaded PLGA nanoparticles for oral
administration: effect of polymer molecular weight and copolymer composition on release
behavior in vitro and in vivo. J Control Release 119:77–85
135. Hans ML, Lowman AM (2002) Biodegradable nanoparticles for drug delivery and targeting.
Curr Opin Solid State Mater Sci 6:319–327
136. Feng SS (2004) Nanoparticles of biodegradable polymers for new-concept chemotherapy.
Expert Rev Med Devices 1:115–125
137. Redhead HM, Davis SS, Illum L (2001) Drug delivery in poly (lactide-co-glycolide)
nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro
characterisation and in vivo evaluation. J Control Release 70:353–363
138. Nicoli S, Santi P, Couvreur P et al (2001) Design of triptorelin loaded nanospheres for
transdermal iontophoretic administration. Int J Pharm 214:31–35
139. Nair LS, Laurencin CT (2006) Polymers as biomaterials for tissue engineering and controlled
drug delivery. In: Kaplan D, Lee K (eds) Tissue engineering I, Advances in biochemical
engineering/biotechnology. Springer, Berlin, pp 47–90
140. Mondrinos MJ, Dembzynski R, Lu L, Byrapogu VK, Wootton DM, Lelkes PI, Zhou J (2006)
Porogen-based solid freeform fabrication of polycaprolactone-calcium phosphate scaffolds
for tissue engineering. Biomaterials 27:4399–4408
141. Gao H, Wang YN, Fan YG et al (2005) Synthesis of a biodegradable tadpole-shaped polymer
via the coupling reaction of polylactide onto mono(6-(2-aminoethyl)amino-6-deoxy)-betacyclodextrin and its properties as the new carrier of protein delivery system. J Control
Release 107:158–173
142. Kim SY, Lee YM (2001) Taxol-loaded block copolymer nanospheres composed of methoxy
poly (ethylene glycol) and poly (epsilon-caprolactone) as novel anticancer drug carriers.
Biomaterials 22:1697–1704
143. Damge C, Maincent P, Ubrich N (2007) Oral delivery of insulin associated to polymeric
nanoparticles in diabetic rats. J Control Release 117:163–170
144. Changyong C, Chae SY, Jae-Won N (2006) Thermosensitive poly(nisopropylacrylamide)-bpoly(E-caprolactone) nanoparticles for efficient drug delivery system. Polymer 47:4571
200
S.K. Pandey et al.
delivery. Int J Technol Assess Health Care 10:121–130
125. Jean-Christophe L, Eric A, Fanny DJ et al (1996) Biodegradable nanoparticles-from
sustained release formulations to improved site specific drug delivery. J Control Release
39:339–350
126. Kumari A, Yadav SK, Pakade YB et al (2011) Nanoencapsulation and characterization of
Albizia chinensis isolated antioxidant quercitrin on PLA nanoparticles. Colloids Surf B
Biointerfaces 82:224–232
127. Hu FX, Neoh KG, Kang ET (2006) Synthesis and in vitro anti-cancer evaluation of
tamoxifen-loaded magnetite/PLLA composite nanoparticles. Biomaterials 27:5725–5733
128. Leenstag JW, Pennings AJ, Bos RRM et al (1987) Resorbable materials of polyl-lactides VI.
Plates and screws for internal fracture fixation. Biomaterials 8:70–73
129. Pathiraja AG, Raju A (2003) Biodegradable synthetic polymers for tissue engineering. Eur
Cell Mater 5:1–16
130. Sheridan MH, Shea LD, Peters MC (2000) Bioabsorbable polymer scaffolds for tissue
engineering capable of sustained growth factor delivery. J Control Release 64:91–102
131. Panyam J, Labhasetwar V (2003) Dynamics of endocytosis and exocytosis of poly (L-lactideco-glycolide) nanoparticles in vascular smooth muscle cells. Pharm Res 20:212–220
132. Prabha S, Labhasetwar V (2004) Critical determinants in PLGA/PLA nanoparticle-mediated
gene expression. Pharm Res 21:354–364
133. Athanasiou KA, Niederauer GG, Agrawal CM (1996) Sterilization, toxicity, biocompatibility
and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials
17:93–102
134. Mittal G, Sahana DK, Bhardwaj V et al (2007) Estradiol loaded PLGA nanoparticles for oral
administration: effect of polymer molecular weight and copolymer composition on release
behavior in vitro and in vivo. J Control Release 119:77–85
135. Hans ML, Lowman AM (2002) Biodegradable nanoparticles for drug delivery and targeting.
Curr Opin Solid State Mater Sci 6:319–327
136. Feng SS (2004) Nanoparticles of biodegradable polymers for new-concept chemotherapy.
Expert Rev Med Devices 1:115–125
137. Redhead HM, Davis SS, Illum L (2001) Drug delivery in poly (lactide-co-glycolide)
nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro
characterisation and in vivo evaluation. J Control Release 70:353–363
138. Nicoli S, Santi P, Couvreur P et al (2001) Design of triptorelin loaded nanospheres for
transdermal iontophoretic administration. Int J Pharm 214:31–35
139. Nair LS, Laurencin CT (2006) Polymers as biomaterials for tissue engineering and controlled
drug delivery. In: Kaplan D, Lee K (eds) Tissue engineering I, Advances in biochemical
engineering/biotechnology. Springer, Berlin, pp 47–90
140. Mondrinos MJ, Dembzynski R, Lu L, Byrapogu VK, Wootton DM, Lelkes PI, Zhou J (2006)
Porogen-based solid freeform fabrication of polycaprolactone-calcium phosphate scaffolds
for tissue engineering. Biomaterials 27:4399–4408
141. Gao H, Wang YN, Fan YG et al (2005) Synthesis of a biodegradable tadpole-shaped polymer
via the coupling reaction of polylactide onto mono(6-(2-aminoethyl)amino-6-deoxy)-betacyclodextrin and its properties as the new carrier of protein delivery system. J Control
Release 107:158–173
142. Kim SY, Lee YM (2001) Taxol-loaded block copolymer nanospheres composed of methoxy
poly (ethylene glycol) and poly (epsilon-caprolactone) as novel anticancer drug carriers.
Biomaterials 22:1697–1704
143. Damge C, Maincent P, Ubrich N (2007) Oral delivery of insulin associated to polymeric
nanoparticles in diabetic rats. J Control Release 117:163–170
144. Changyong C, Chae SY, Jae-Won N (2006) Thermosensitive poly(nisopropylacrylamide)-bpoly(E-caprolactone) nanoparticles for efficient drug delivery system. Polymer 47:4571
200
S.K. Pandey et al.